Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
221 hedge funds and large institutions have $2.89B invested in Axonics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 80 increasing their positions, 77 reducing their positions, and 53 closing their positions.
45% more call options, than puts
Call options by funds: $4.72M | Put options by funds: $3.26M
11% more capital invested
Capital invested by funds: $2.59B → $2.89B (+$294M)
4% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 77
6% less funds holding
Funds holding: 235 → 221 (-14)
25% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 53
Top Buyers
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$40.8M |
| 2 |
FAM
Fred Alger Management
New York
|
-$30M |
| 3 |
RI
RTW Investments
New York
|
-$24.9M |
| 4 |
Millennium Management
New York
|
-$20.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.5M |
AXNX Hedge Fund Activity: Q3 2023 in Review
221 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q3 2023, worth a combined $2.89B — up 11% from $2.59B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of AXNX and 40 opened new positions — a net loss of 13 holders — while 77 trimmed existing stakes and 80 added.
The largest buyer was Fidelity Investments, adding an estimated $107M. The largest seller was Marshall Wace, cutting an estimated $40.8M.
- 221 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q3 2023, down from 235 in Q2 2023.
- Funds reported $2.89B of Axonics, Inc. Common Stock stock for Q3 2023, up 11% quarter-over-quarter.
- 40 funds opened new Axonics, Inc. Common Stock positions in Q3 2023 and 53 closed out, a net change of -13 holders.
- The largest Axonics, Inc. Common Stock buyer in Q3 2023 was Fidelity Investments, an estimated $107M added.
- The largest Axonics, Inc. Common Stock seller in Q3 2023 was Marshall Wace, an estimated $40.8M sold.
Based on aggregated 13F filings for Q3 2023.